Teladoc Health
Stock Forecast, Prediction & Price Target
Teladoc Health (TDOC) stock Price Target by analysts
Teladoc Health (TDOC) stock Price Target by analysts
Average Price Target
$11
Potential upside: 49.65%
Teladoc Health price prediction
What is Teladoc Health stock analysts` prediction?
Teladoc Health stock forecast: Based on 3 Wall Street analysts` predicted price targets for Teladoc Health in the last 3 months, the avarage price target is $11, with a high forecast of $NaN. The average price target represents a 49.65% change from the last price of $7.35.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Teladoc Health stock Price Target by analysts
Full breakdown of analysts given Teladoc Health price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Jessica Tassan Piper Sandler | 50% 2/4 | 10 months ago | $13 76.87% upside | $11.01 | StreetInsider | Previous targets (3) |
Daniel Grosslight Citigroup | 0% 0/1 | 11 months ago | $11 49.65% upside | $8.86 | StreetInsider | Previous targets (0) |
Elizabeth Anderson Evercore ISI | 0% 0/1 | 11 months ago | $9 22.44% upside | $8.86 | StreetInsider | Previous targets (0) |
Jessica Tassan Piper Sandler | 50% 2/4 | about 1 year ago | $10 36.05% upside | $7.6 | TheFly | Previous targets (3) |
Steve Valiquette Barclays | 0% 0/2 | over 1 year ago | $20 172.10% upside | $10.49 | StreetInsider | Previous targets (1) |
Glen Santangelo Jefferies | 0% 0/3 | over 1 year ago | $10 36.05% upside | $11.29 | StreetInsider | Previous targets (2) |
Glen Santangelo Jefferies | 0% 0/3 | over 1 year ago | $14 90.47% upside | $12.39 | TheFly | Previous targets (2) |
George Hill Deutsche Bank | 0% 0/1 | over 1 year ago | $18 144.89% upside | $14.65 | StreetInsider | Previous targets (0) |
Jeff Garro Stephens | 100% 1/1 | over 2 years ago | $25 240.13% upside | $25.86 | Benzinga | Previous targets (0) |
Unknown Citigroup | N/A | almost 3 years ago | $33 348.97% upside | $27.63 | Benzinga | N/A |
Unknown RBC Capital | N/A | almost 3 years ago | $35 376.19% upside | $27.52 | Benzinga | N/A |
Unknown Deutsche Bank | N/A | about 3 years ago | $31 321.76% upside | $26.37 | Benzinga | N/A |
Steve Valiquette Barclays | 0% 0/2 | about 3 years ago | $42 471.42% upside | $36.85 | Pulse 2.0 | Previous targets (1) |
Unknown Barclays | N/A | about 3 years ago | $40 444.21% upside | $33.82 | Benzinga | N/A |
Jessica Tassan Piper Sandler | 50% 2/4 | about 3 years ago | $40 444.21% upside | $43.24 | TheFly | Previous targets (3) |
Unknown Oppenheimer | N/A | about 3 years ago | $55 648.29% upside | $43.24 | Benzinga | N/A |
Unknown Barclays | N/A | about 3 years ago | $42 471.42% upside | $41.15 | Benzinga | N/A |
Unknown Stifel Nicolaus | N/A | about 3 years ago | $36 389.79% upside | $34.34 | Benzinga | N/A |
Unknown Goldman Sachs | N/A | over 3 years ago | $55 648.29% upside | $33.58 | Benzinga | N/A |
Jessica Tassan Piper Sandler | 50% 2/4 | over 3 years ago | $42 471.42% upside | $32.85 | TipRanks Contributor | Previous targets (3) |
Stan Berenshteyn Wells Fargo | 100% 1/1 | over 3 years ago | $40 444.21% upside | $33.51 | TheFly | Previous targets (0) |
Jonathan Yong Credit Suisse | 100% 1/1 | over 3 years ago | $35 376.19% upside | $33.51 | TheFly | Previous targets (0) |
Unknown Credit Suisse | N/A | over 3 years ago | $35 376.19% upside | $55.99 | Benzinga | N/A |
Stephanie Davis Leerink Partners | 100% 1/1 | over 3 years ago | $35 376.19% upside | $33.51 | TipRanks Contributor | Previous targets (0) |
Unknown Citigroup | N/A | over 3 years ago | $43 485.03% upside | $29.3 | Benzinga | N/A |
Unknown Craig-Hallum | N/A | over 3 years ago | $30 308.16% upside | $33.77 | Benzinga | N/A |
Elizabeth Anderson CFA Evercore ISI | 100% 2/2 | over 3 years ago | $30 308.16% upside | $33.51 | TipRanks Contributor | Previous targets (1) |
Unknown Leerink Partners | N/A | over 3 years ago | $35 376.19% upside | $55.99 | Benzinga | N/A |
Dev Weerasuriya Berenberg Bank | 0% 0/2 | over 3 years ago | $141 1818.36% upside | $33.51 | TipRanks Contributor | Previous targets (1) |
Steven Valiquette Barclays | 0% 0/2 | over 3 years ago | $45 512.24% upside | $33.51 | TheFly | Previous targets (1) |
Sean Dodge RBC Capital | 0% 0/1 | over 3 years ago | $65 784.35% upside | $33.51 | StreetInsider | Previous targets (0) |
Unknown Canaccord Genuity | N/A | over 3 years ago | $50 580.27% upside | $33.78 | Benzinga | N/A |
Unknown Deutsche Bank | N/A | over 3 years ago | $44 498.63% upside | $33.84 | Benzinga | N/A |
Unknown RBC Capital | N/A | over 3 years ago | $65 784.35% upside | $29.38 | Benzinga | N/A |
Unknown Needham | N/A | over 3 years ago | $48 553.06% upside | $55.99 | Benzinga | N/A |
Vikram Kesavabhotla Robert W. Baird | 100% 2/2 | over 3 years ago | $38 417.00% upside | $55.99 | TheFly | Previous targets (1) |
Charles Rhyee Cowen & Co. | 0% 0/1 | over 3 years ago | $94 1178.91% upside | $68.96 | Pulse 2.0 | Previous targets (0) |
Dev Weerasuriya Berenberg Bank | 0% 0/2 | over 3 years ago | $141 1818.36% upside | $75.91 | TipRanks Contributor | Previous targets (1) |
Glen Santangelo Jefferies | 0% 0/3 | over 3 years ago | $82 1015.64% upside | $75.91 | TipRanks Contributor | Previous targets (2) |
Vikram Kesavabhotla Robert W. Baird | 100% 2/2 | over 3 years ago | $72 879.59% upside | $61.46 | TheFly | Previous targets (1) |
Elizabeth Anderson CFA Evercore ISI | 100% 2/2 | over 3 years ago | $70 852.38% upside | $61.46 | StreetInsider | Previous targets (1) |
David Grossman Stifel Nicolaus | 100% 1/1 | over 3 years ago | $74 906.80% upside | $61.46 | Benzinga | Previous targets (0) |
Matt Hewitt Craig-Hallum | 100% 1/1 | over 3 years ago | $67 811.56% upside | $61.46 | TheFly | Previous targets (0) |
Michael Wiederhorn Oppenheimer | 0% 0/1 | over 3 years ago | $130 1668.70% upside | $61.46 | TheFly | Previous targets (0) |
Richard Close Canaccord Genuity | 0% 0/1 | over 3 years ago | $112 1423.80% upside | $61.46 | TheFly | Previous targets (0) |
Lisa Gill J.P. Morgan | 0% 0/1 | over 3 years ago | $125 1600.68% upside | $61.46 | TheFly | Previous targets (0) |
Ryan MacDonald Needham | 0% 0/1 | over 3 years ago | $100 1260.54% upside | $61.46 | TipRanks Contributor | Previous targets (0) |
Donald Hooker KeyBanc | 0% 0/1 | over 3 years ago | $100 1260.54% upside | $61.46 | Benzinga | Previous targets (0) |
Steven Valiquette Barclays | 0% 0/2 | over 3 years ago | $77 947.61% upside | $61.46 | TheFly | Previous targets (1) |
Steve Baxter Wells Fargo | 0% 0/1 | over 3 years ago | $121 1546.25% upside | $81.76 | TipRanks Contributor | Previous targets (0) |
Teladoc Health Financial Estimates
Teladoc Health Revenue Estimates
Teladoc Health EBITDA Estimates
Teladoc Health Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $2.03B N/A | $2.40B 18.40% | $2.60B 8.12% | Avg: $2.75B Low: $2.69B High: $2.80B avg. 5.84% | Avg: $2.86B Low: $2.81B High: $2.91B avg. 4.07% | Avg: $2.96B Low: $2.91B High: $3.00B avg. 3.37% | Avg: $3.11B Low: $3.06B High: $3.16B avg. 5.18% |
Net Income
% change YoY
| $-428.79M N/A | $-13.65B -3085.57% | $-220.36M 98.38% | Avg: $-110.52M Low: $-194.20M High: $-27.97M avg. 49.84% | Avg: $-83.18M Low: $-138.24M High: $55.95M avg. 24.74% | Avg: $-6.78M Low: $-6.92M High: $-6.63M avg. 91.84% | Avg: $69.94M Low: $68.40M High: $71.34M avg. 1130.75% |
EBITDA
% change YoY
| $-14.27M N/A | $13.46B 94428.20% | $153.99M -98.85% | Avg: $387.68M Low: $379.22M High: $394.72M avg. 151.74% | Avg: $403.48M Low: $396.64M High: $409.71M avg. 4.07% | Avg: $417.12M Low: $410.05M High: $423.56M avg. 3.37% | Avg: $438.76M Low: $431.32M High: $445.53M avg. 5.18% |
EPS
% change YoY
| -$2.73 N/A | -$84.6 -2998.90% | -$1.36 98.39% | Avg: -$0.67 Low: -$1.18 High: -$0.17 avg. 50.48% | Avg: -$0.53 Low: -$0.84 High: $0.34 avg. 21.61% | Avg: -$0.04 Low: -$0.04 High: -$0.04 avg. 92.18% | Avg: $0.43 Low: $0.42 High: $0.43 avg. 1130.75% |
Operating Expenses
% change YoY
| $1.62B N/A | $1.89B 16.57% | $2.09B 10.61% | Avg: $1.67B Low: $1.63B High: $1.70B avg. -20.08% | Avg: $1.73B Low: $1.70B High: $1.76B avg. 4.07% | Avg: $1.79B Low: $1.76B High: $1.82B avg. 3.37% | Avg: $1.89B Low: $1.85B High: $1.92B avg. 5.18% |
FAQ
What is Teladoc Health stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 324.29% in 2025-2028.
We have gathered data from 16 analysts. Their low estimate is -194.20M, average is -110.52M and high is -27.97M.
What is Teladoc Health stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 4.62% in 2025-2028.
We have gathered data from 20 analysts. Their low revenue estimate is $2.69B, average is $2.75B and high is $2.80B.
What is Teladoc Health stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 323.75% in 2025-2028.
We have gathered data from 16 analysts. Their low earnings per share estimate is -$1.18, average is -$0.67 and high is $-0.17.
What is the best performing analyst?
In the last twelve months 3 analysts have been covering Teladoc Health stock. The most successful analyst is Jessica Tassan whose win rate is 50%. He has correctly predicted 2/4 price targets.